Squires M. et al. “AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples.” Molecular Cancer Therapeutics 9, no. 4 2010: 920-928. DOI: 10.1158/1535-7163.MCT-09-1071.
Squires M. et al. “AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples.” Molecular Cancer Therapeutics 9, no. 4 2010: 920-928. DOI: 10.1158/1535-7163.MCT-09-1071.
